Smith Group Asset Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-50
Closed -$3K 376
2021
Q2
$3K Hold
50
﹤0.01% 352
2021
Q1
$5K Sell
50
-1,390
-97% -$139K ﹤0.01% 307
2020
Q4
$129K Sell
1,440
-10
-0.7% -$896 0.01% 199
2020
Q3
$150K Sell
1,450
-310
-18% -$32.1K 0.01% 183
2020
Q2
$139K Sell
1,760
-30
-2% -$2.37K 0.01% 182
2020
Q1
$104K Hold
1,790
0.01% 212
2019
Q4
$97K Hold
1,790
﹤0.01% 240
2019
Q3
$94K Buy
1,790
+320
+22% +$16.8K ﹤0.01% 243
2019
Q2
$71K Sell
1,470
-220
-13% -$10.6K ﹤0.01% 256
2019
Q1
$85K Sell
1,690
-4,584
-73% -$231K ﹤0.01% 269
2018
Q4
$372K Sell
6,274
-103
-2% -$6.11K 0.01% 205
2018
Q3
$420K Buy
6,377
+5,970
+1,467% +$393K 0.01% 204
2018
Q2
$21K Buy
407
+25
+7% +$1.29K ﹤0.01% 384
2018
Q1
$20K Hold
382
﹤0.01% 395
2017
Q4
$18K Hold
382
﹤0.01% 405
2017
Q3
$15K Hold
382
﹤0.01% 414
2017
Q2
$13K Hold
382
﹤0.01% 419
2017
Q1
$11K Hold
382
﹤0.01% 404
2016
Q4
$13K Hold
382
﹤0.01% 404
2016
Q3
$12K Sell
382
-7,010
-95% -$220K ﹤0.01% 406
2016
Q2
$208K Buy
7,392
+7,010
+1,835% +$197K 0.01% 249
2016
Q1
$14K Sell
382
-20
-5% -$733 ﹤0.01% 383
2015
Q4
$16K Sell
402
-3
-0.7% -$119 ﹤0.01% 404
2015
Q3
$12K Hold
405
﹤0.01% 349
2015
Q2
$13K Sell
405
-3
-0.7% -$96 ﹤0.01% 337
2015
Q1
$12K Buy
408
+180
+79% +$5.29K ﹤0.01% 377
2014
Q4
$6K Hold
228
﹤0.01% 387
2014
Q3
$5K Sell
228
-350
-61% -$7.68K ﹤0.01% 358
2014
Q2
$13K Sell
578
-52,036
-99% -$1.17M ﹤0.01% 323
2014
Q1
$1.33M Buy
+52,614
New +$1.33M 0.05% 174